Pregnancy Risks and Contraception in Women with Fontan Circulation
Women with Fontan circulation face extremely high pregnancy risks (WHO Class III-IV) and must avoid estrogen-containing contraceptives due to thrombotic risk; progesterone-only methods, intrauterine devices, or permanent sterilization are the safest contraceptive options.
Pregnancy Risks: High Maternal and Fetal Morbidity
Women with Fontan physiology carry substantial pregnancy risks that warrant intensive preconception counseling. The 2018 AHA/ACC guidelines explicitly classify Fontan patients as high-risk, noting they have "extremely high risk of maternal mortality or severe morbidity" 1. The ESC guidelines similarly advise careful counseling, noting these are WHO Class III or IV pregnancies 2.
Maternal Complications
The hemodynamic burden of pregnancy is poorly tolerated in Fontan circulation:
- Cardiac decompensation occurs in approximately 50% of pregnancies, with some requiring hospitalization 3
- Arrhythmias (particularly atrial flutter and supraventricular tachycardia) complicate many pregnancies 4, 3
- Thrombotic events remain a significant concern given the prothrombotic state of both pregnancy and Fontan physiology 2, 4
- Heart failure can develop or worsen, particularly in those with pre-existing ventricular dysfunction 1
Recent data shows that while acute complications during pregnancy are common, medium-term functional decline may be limited in selected patients 5. However, ejection fraction can worsen post-pregnancy more than in matched controls 5.
Fetal and Obstetric Complications
The fetal outcomes are sobering:
- Miscarriage rate: 50-53% across multiple studies 4, 3, 6
- Preterm delivery is common, with mean gestational age around 33-36 weeks 4, 3, 6
- Low birth weight (mean ~2,086-2,344g) 4, 6
- Small for gestational age infants occur frequently 2, 7
- Obstetric complications (particularly bleeding) affect nearly half of pregnancies 5
High-Risk Features Contraindicating Pregnancy
The guidelines identify specific features that should lead to strong counseling against pregnancy 1, 2:
- Oxygen saturation <85% at rest
- Significant ventricular dysfunction (EF <40%)
- NYHA Class III-IV symptoms
- Moderate to severe atrioventricular valve regurgitation
- Protein-losing enteropathy
- Non-optimal Fontan circuit
If pregnancy occurs in these high-risk patients, pregnancy termination should be discussed 1.
Contraceptive Recommendations: Avoid Estrogen
Contraindicated: Estrogen-Containing Methods
The 2018 AHA/ACC guidelines provide a Class III (Harm) recommendation against estrogen-containing contraceptives in Fontan patients 1. Fontan physiology is explicitly listed as a high thrombotic risk state where estrogen is potentially harmful. This is non-negotiable given the already elevated thrombotic risk in these patients.
Real-world data supports this concern: among 138 women with Fontan circulation, 6 experienced thrombotic complications, though only one was using oral contraceptives 4. The baseline thrombotic risk is substantial even without estrogen exposure.
Recommended Contraceptive Options
Given the high pregnancy risks and contraindication to estrogen, highly effective non-estrogen contraception is essential 1:
First-Line Options:
Intrauterine devices (IUDs) - Highly effective with no thrombotic risk
- Caveat: Risk of vasovagal reaction at insertion; consider prophylactic atropine and placement in a monitored setting 1
- Both copper and levonorgestrel IUDs are appropriate
Progesterone-only methods:
- Progesterone-only pills (though require strict adherence)
- Progestin implants (etonogestrel)
- Note: Medroxyprogesterone acetate (Depo-Provera) is less effective and carries fluid retention risk, making it less ideal 1
Permanent sterilization:
Less Reliable Options:
- Barrier methods alone have high failure rates (~12% use in one cohort) 4
- Notably, 44% of women in one study used no contraception 4, highlighting the critical need for proactive counseling
Critical Counseling Points
All women of childbearing age with Fontan circulation require comprehensive contraceptive counseling that includes 1:
- Expected failure rates of each method
- Maternal and fetal risks of unplanned pregnancy (50% miscarriage rate, high maternal morbidity)
- The specific contraindication to estrogen-containing methods
- Regular reassessment of contraceptive needs
Anticoagulation Considerations
The ESC guidelines suggest anticoagulation should be considered during pregnancy in Fontan patients (Class IIa) 2. For contraception counseling, this means:
- Women already on warfarin face additional complexity, as the interaction between warfarin and estrogen-containing contraceptives is unclear 1
- This does not make estrogen safe—it remains contraindicated
- Prophylactic anticoagulation may be needed during pregnancy itself, particularly with assisted reproductive technology 8
Special Consideration: Assisted Reproductive Technology
For women pursuing fertility treatment, additional thrombotic risk from ovarian stimulation must be considered, with prophylactic anticoagulation (enoxaparin) recommended during stimulation cycles 8.
Clinical Algorithm for Contraceptive Selection
- Confirm Fontan physiology → Estrogen contraceptives are absolutely contraindicated
- Assess patient preferences and compliance ability:
- High compliance → Progesterone-only pills acceptable
- Prefer long-acting → IUD or implant (first choice)
- Completed childbearing → Consider permanent sterilization
- Pre-IUD insertion: Plan for monitored setting with atropine available
- Avoid Depo-Provera due to fluid retention risk in this population
- Document counseling regarding 50% miscarriage risk and maternal morbidity if pregnancy occurs
Preconception Planning If Pregnancy Desired
For the rare patient with favorable features (younger age, normal weight, no functional limitation, good ventricular function, no Fontan complications) who desires pregnancy 9:
- Multidisciplinary pregnancy heart team evaluation before conception 8
- Cardiopulmonary exercise testing to assess functional capacity 1
- Detailed echocardiographic assessment of ventricular function and valve regurgitation
- Discussion of 50% miscarriage rate and high preterm delivery risk
- Plan for therapeutic anticoagulation during pregnancy 2
- Delivery at tertiary center with frequent monitoring (every 4 weeks) 2